Effects of dilution and prolonged storage with preservative in a polyethylene container on Bevacizumab (Avastin™) for topical delivery as a nasal spray in anti-hereditary hemorrhagic telangiectasia and related therapies
Human Antibodies · 24.11.2011 · 20 (3-4) · 95-101
DOI: 10.3233/hab-2011-0244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Antibodies, erschienen am 24.11.2011. Verfasst von Simon Kaja und 5 weiteren Autor:innen. Beteiligte Einrichtung: Vision Research Center and Department of Ophthalmology, University of Missouri - Kansas City, School of Medicine, Kansas City, MO 64108, USA. Die Arbeit wurde bisher 32-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCRR NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Vision Research Center and Department of Ophthalmology, University of Missouri - Kansas City, School of Medicine, Kansas City, MO 64108, USA.
Förderung
- NCRR NIH HHS
Zitieren
APA
Kaja, S., Hilgenberg, J. D., Everett, E., Olitsky, S. E., Gossage, J., & Koulen, P. (2011). Effects of dilution and prolonged storage with preservative in a polyethylene container on Bevacizumab (Avastin™) for topical delivery as a nasal spray in anti-hereditary hemorrhagic telangiectasia and related therapies. Human Antibodies, 20(3-4), 95-101. https://doi.org/10.3233/hab-2011-0244
Vancouver
Kaja S, Hilgenberg JD, Everett E, Olitsky SE, Gossage J, Koulen P. Effects of dilution and prolonged storage with preservative in a polyethylene container on Bevacizumab (Avastin™) for topical delivery as a nasal spray in anti-hereditary hemorrhagic telangiectasia and related therapies. Human Antibodies. 2011;20(3-4):95-101. doi:10.3233/hab-2011-0244
BibTeX
@article{Kaja2011,
author = {Kaja, Simon and Hilgenberg, Jill D and Everett, Eric and Olitsky, Scott E and Gossage, Jim and Koulen, Peter},
title = {Effects of dilution and prolonged storage with preservative in a polyethylene container on Bevacizumab (Avastin™) for topical delivery as a nasal spray in anti-hereditary hemorrhagic telangiectasia and related therapies},
journal = {Human Antibodies},
year = {2011},
volume = {20},
number = {3-4},
pages = {95--101},
doi = {10.3233/hab-2011-0244}
}
EUVIMED